文献速递血液净化与透析

雌二醇与终末期肾病女性死亡率的关系

Estradiol and mortality in women with end-stage kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

本研究在482例开始血液透析的加拿大女性终末期肾病患者中,按雌二醇水平五分位分组,随访平均2.9年。结果发现,与最低五分位相比,较高雌二醇水平(第4、5五分位)与全因死亡率和非心血管死亡率升高相关,但与心血管死亡率无关。

要点

  • 较高雌二醇水平与ESKD女性全因死亡风险增加独立相关。
  • 雌二醇水平与心血管死亡率无显著关联。
  • 仅在老年女性中观察到雌二醇与全因及非心血管死亡率的趋势关联。

核心结论

  • 在血液透析的终末期肾病女性中,较高雌二醇水平与全因死亡率和非心血管死亡率升高相关。

研究设计与样本

  • 多中心前瞻性队列研究,纳入2005-2012年间加拿大4个中心开始血液透析的482例女性ESKD患者。

主要发现

  • 平均随访2.9年,共237例死亡,其中心血管死亡占31%。
  • 与雌二醇最低五分位(均值19.3 pmol/L)相比,第4五分位(108.9 pmol/L)和第5五分位(355 pmol/L)的全因死亡率调整HR分别为2.12(95%CI 1.38-3.25)和1.92(95%CI 1.19-3.10)。
  • 与最低五分位相比,第5五分位的非心血管死亡率HR为2.16(95%CI 1.18-3.96)。
  • 雌二醇水平与心血管死亡率无显著关联。
  • 在老年女性中,较高五分位与全因死亡率(趋势P<0.001)和非心血管死亡率(趋势P=0.02)增加相关,但与心血管死亡率无关。

临床怎么用

  • 在评估ESKD女性死亡风险时,高雌二醇水平可能提示需要关注,但尚不能作为常规风险分层指标。

局限性

  • 观察性设计不能确定因果关系,机制尚不明确,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Young women with end-stage kidney disease (ESKD) have early menopause compared with women in the general population and the highest mortality among the dialysis population. We hypothesized that low estrogen status was associated with death in women with ESKD. METHODS: We measured estradiol and sex hormone levels in female ESKD patients initiating hemodialysis from 2005 to 2012 in four Canadian centers. We divided women into quintiles based on estradiol levels and tested for associations between the estradiol level and cardiovascular (CV), non-CV and all-cause mortality. Participants were further dichotomized by age. RESULTS: A total of 482 women (60 ± 15 years of age, 53% diabetic, estradiol 116 ± 161 pmol/L) were followed for a mean of 2.9 years, with 237 deaths (31% CV). Estradiol levels were as follows (mean ± standard deviation): Quintile 1: 19.3 ± 0.92 pmol/L; Quintile 2: 34.6 ± 6.6 pmol/L; Quintile 3: 63.8 ± 10.6 pmol/L; Quintile 4: 108.9 ± 19.3; Quintile 5: 355 ± 233 pmol/L. Compared with Quintile 1, women in Quintiles 4 and 5 had significantly higher adjusted all-cause mortality {hazard ratio [HR] 2.12 [95% confidence interval (CI) 1.38-3.25] and 1.92 [1.19-3.10], respectively}. Similarly, compared with Quintile 1, women in Quintile 5 had higher non-CV mortality [HR 2.16 (95% CI 1.18-3.96)]. No associations were observed between estradiol levels and CV mortality. When stratified by age, higher quintiles were associated with greater all-cause mortality (P for trend <0.001) and non-CV mortality (P for trend = 0.02), but not CV mortality in older women. CONCLUSIONS: In women with ESKD treated with hemodialysis, higher estradiol levels were associated with greater all-cause and non-CV mortality. Further studies are required to determine the mechanism for the observed increased risk.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Ramesh S, James MT, Holroyd-Leduc JM, et al. Estradiol and mortality in women with end-stage kidney disease. Nephrol Dial Transplant. 2020. PMID: 32865207. doi:10.1093/ndt/gfaa126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。